Kevin Healy, professor of bioengineering and materials science and engineering, leads Berkeley’s role in a new craniofacial research center, C-DOCTOR. UC Berkeley is part of a California-based, six-university consortium that has been awarded $12 million by the National Institutes of Health to develop strategies for treating craniofacial defects, which affect millions of Americans.
Category: UC San Francisco
Mission Bio Receives Investment from Life Science Angels
Mission Bio, Inc. announced today that it has secured funding from U.S. top ranked angel investment group Life Science Angels in a seed round to commercialize its high throughput single-cell genomics system. Mission Bio is developing a microfluidic, droplet-based platform to enable critical advances in diseases like cancer, where elucidating heterogeneity in cell populations is essential.